BP186

Hydrochlorothiazide

British Pharmacopoeia (BP) Reference Standard

• 동의어(들): 6-Chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide, 6-Chloro-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide
• 실험식(Hill 표기법): C₇H₈ClN₃O₄S₂
• CAS Number: 58-93-5
• Molecular Weight: 297.74
• MDL number: MFCD00051765
• UNSPSC 코드: 12352125
• NACRES: NA.24

속성

• Grade: pharmaceutical primary standard
• API family: hydrochlorothiazide
• 양식: solid
• 유통기한: limited shelf life, expiry date on the label
• 제조업체/상표: BP
• 응용 분야: pharmaceutical; pharmaceutical small molecule
• 형식: neat
• SMILES string: NS(=O)(=O)c1cc2c(NCNS2(=O)=O)cc1Cl
• InChI: 1S/C7H8ClN3O4S2/c8-4-1-5-7(2-6(4)16(9,12)13)17(14,15)11-3-10-5/h1-2,10-11H,3H2,(H2,9,12,13)
• InChI key: JZUFKLXOESDKRF-UHFFFAOYSA-N
• 유전자 정보: human ... SLC12A3(6559)

설명

일반 설명

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

애플리케이션

Hydrochlorothiazide BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:

Co-amilozide Tablets

Co-amilozide Oral Solution

Hydrochlorothiazide Tablets

Co-triamterzide Tablets

생화학적/생리학적 작용

Carbonic anhydrase inhibitor

포장

Unit quantity: 200 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

기타 정보

Sales restrictions may apply.

안전성 정보

• 픽토그램: GHS08
• 신호어: Warning
• 유해 및 위험 성명서: H351
• 예방조치 성명서: P201 - P202 - P280 - P308 + P313 - P405 - P501
• Hazard Classifications: Carc. 2
• Storage Class Code: 11 - Combustible Solids
• WGK: WGK 2
• Flash Point (°F): Not applicable
• Flash Point (°C): Not applicable